10X Genomics Inc
NASDAQ:TXG
10X Genomics Inc
NASDAQ:TXG
Price:
27.48 USD
4.53%
Market Closed
Updated:
May 5, 2024
10X Genomics Inc
Revenue
|
10X Genomics Inc
Revenue Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
10X Genomics Inc
NASDAQ:TXG
|
Revenue
$625.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
10X Genomics Inc
Revenue Breakdown
Breakdown by Geography
10X Genomics Inc
10X Genomics Inc
|
Total Revenue:
618.7m
USD
|
|
Americas:
373.2m
USD
|
|
United States:
360.1m
USD
|
|
EMEA:
142.3m
USD
|
|
Asia Pacific:
103.3m
USD
|
|
Asia-Pacific, Excluding China:
52.3m
USD
|
|
China:
51m
USD
|
|
Americas, Excluding United States:
13.1m
USD
|
Breakdown by Segments
10X Genomics Inc
10X Genomics Inc
|
Total Revenue:
618.7m
USD
|
|
Consumables:
479.6m
USD
|
|
Instruments:
123.5m
USD
|
|
Services:
15.7m
USD
|
See Also
What is 10X Genomics Inc's Revenue?
Revenue
625.4m
USD
625.4m
USD
Based on the financial report for Mar 31, 2024, 10X Genomics Inc's Revenue amounts to 625.4m USD.
What is 10X Genomics Inc's Revenue growth rate?
Revenue CAGR 5Y
29%
29%
Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for 10X Genomics Inc have been 23% over the past three years , 29% over the past five years .
You don't have any saved screeners yet
